1Department of Anesthesiology and Critical Care Medicine, CHU Amiens Picardie, Amiens, France.
2INSERM UMR 1088, University of Picardy Jules Verne, Amiens, France.
3Mycology Laboratory, CHU Amiens Picardie, Amiens, France.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (http://journals.lww.com/ccmjournal).
Drs. Dupont, Mahjoub, and Zogheib designed the study. Drs. Dupont and Mahjoub performed the literature search. Drs. Dupont and Zogheib extracted the date and classified the studies. Discrepancies were resolved with Dr. Mahjoub, Mr. Chouaki, and Dr. Lorne. Dr. Dupont performed statistical analysis. Drs. Dupont, Mahjoub, Mr. Chouaki, and Drs. Lorne and Zogheib interpreted the results. Drs. Dupont, Mahjoub, and Zogheib wrote the first draft of the article, which all authors critically revised for important intellectual content. Dr. Dupont wrote the final version, which all the authors approved for publication.
Dr. Dupont has been a consultant and member of the boards for Astellas, Pfizer, Gilead, Basilea, and Merck Sharp and Dohme (MSD). Dr. Zogheib has received conference and congress fees from Astellas, MSD, and Pfizer. Mr. Chouaki has received conference and congress fees from Astellas, MSD, Gilead, and Pfizer. The remaining authors have disclosed that they do not have any potential conflicts of interest.
For information regarding this article, E-mail: [email protected]